Shire Regulatory News (SHP)

Shire Information

There is currently no data for SHP

Form 8.3 - Shire Plc

12 Dec 2018 10:24

RNS Number : 2587K

Societe Generale SA

12 December 2018

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:	Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree	Shire Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure	11/12/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"	YES: Takeda Pharmaceutical Company Limited

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:	Ordinary shares: 15,757,337 Shares Interests and 13,130,470 short position ADR (referencing the ordinary): 526,485 equivalent Shares interests and 46,638 equivalent Shares as short position Where (1 ADR = 3 ordinary shares)
	Interests		Short positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled:	16,283,822	1.78	13,177,108	1.44
(2) Cash-settled derivatives:	13,816,869	1.51	14,664,097	1.60
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	275,700	0.03	226,800	0.02
TOTAL:	30,376,391	3.32	28,068,005	3.06

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit GBP
Ordinary	Purchase	51	45.015
Ordinary	Purchase	53	45.015
Ordinary	Purchase	37	45.015
Ordinary	Purchase	77	45.065
Ordinary	Purchase	17	45.175
Ordinary	Purchase	65	45.18
Ordinary	Purchase	90	45.18
Ordinary	Purchase	91	45.125
Ordinary	Purchase	116	44.985
Ordinary	Purchase	122	45
Ordinary	Purchase	122	45
Ordinary	Purchase	126	45.015
Ordinary	Purchase	95	45.015
Ordinary	Purchase	37	44.985
Ordinary	Purchase	63	45.195
Ordinary	Purchase	70	45.115
Ordinary	Purchase	76	45.085
Ordinary	Purchase	15	45.03
Ordinary	Purchase	51	45.03
Ordinary	Purchase	80	45.015
Ordinary	Purchase	65	45.065
Ordinary	Purchase	28	45.015
Ordinary	Purchase	65	45
Ordinary	Purchase	1	45
Ordinary	Purchase	95	45.11
Ordinary	Purchase	218	45.1
Ordinary	Purchase	95	45.12
Ordinary	Purchase	176	45.195
Ordinary	Purchase	119	45.195
Ordinary	Purchase	21	45.24
Ordinary	Purchase	62	45.24
Ordinary	Purchase	68	44.985
Ordinary	Purchase	17	45.025
Ordinary	Purchase	304	45.235
Ordinary	Purchase	161	45.235
Ordinary	Purchase	260	45.19
Ordinary	Purchase	260	45.175
Ordinary	Purchase	123	45.23
Ordinary	Purchase	117	45.23
Ordinary	Purchase	10	45.23
Ordinary	Purchase	10	45.23
Ordinary	Purchase	300	45.08
Ordinary	Purchase	157	45.08
Ordinary	Purchase	303	45.175
Ordinary	Purchase	249	45.15
Ordinary	Purchase	11	45.15
Ordinary	Purchase	103	45.13
Ordinary	Purchase	938	45.13
Ordinary	Purchase	693	45.13
Ordinary	Purchase	260	45.15
Ordinary	Purchase	395	45.13
Ordinary	Purchase	260	45.21
Ordinary	Purchase	144	45.015
Ordinary	Purchase	124	45
Ordinary	Purchase	120	45.01
Ordinary	Purchase	52	45.01
Ordinary	Purchase	262	45.185
Ordinary	Purchase	101	45.015
Ordinary	Purchase	539	45.015
Ordinary	Purchase	260	45.13
Ordinary	Purchase	30	45.195
Ordinary	Purchase	129	45.195
Ordinary	Purchase	229	45.255
Ordinary	Purchase	232	45.175
Ordinary	Purchase	74	45.175
Ordinary	Purchase	260	45.205
Ordinary	Purchase	126	45.2
Ordinary	Purchase	134	45.2
Ordinary	Purchase	97	45.02
Ordinary	Purchase	188	45.15
Ordinary	Purchase	72	45.15
Ordinary	Purchase	150	45.105
Ordinary	Purchase	204	45.015
Ordinary	Purchase	1,211	45.11
Ordinary	Purchase	101	45.11
Ordinary	Purchase	150	45.11
Ordinary	Purchase	85	45.19
Ordinary	Purchase	175	45.19
Ordinary	Purchase	202	45.045
Ordinary	Purchase	50	45.065
Ordinary	Purchase	78	45.015
Ordinary	Purchase	262	45.185
Ordinary	Purchase	260	45.13
Ordinary	Purchase	260	45.235
Ordinary	Purchase	125	45.145
Ordinary	Purchase	84	45.02
Ordinary	Purchase	142	45.06
Ordinary	Purchase	8	45.06
Ordinary	Purchase	35	45.18
Ordinary	Purchase	75	45.11
Ordinary	Purchase	70	45.08
Ordinary	Purchase	75	45.08
Ordinary	Purchase	117	45.08
Ordinary	Purchase	70	45.08
Ordinary	Purchase	112	45.08
Ordinary	Purchase	67	45.175
Ordinary	Purchase	60	45.1
Ordinary	Purchase	27	45.105
Ordinary	Purchase	67	45.105
Ordinary	Purchase	65	45.105
Ordinary	Purchase	40	45.105
Ordinary	Purchase	73	45.125
Ordinary	Purchase	78	45.125
Ordinary	Purchase	52	45.115
Ordinary	Purchase	48	45.115
Ordinary	Purchase	73	45.12
Ordinary	Purchase	360	45.15
Ordinary	Purchase	104	45.135
Ordinary	Purchase	107	45.055
Ordinary	Purchase	78	45.005
Ordinary	Purchase	111	45.005
Ordinary	Purchase	253	45.07
Ordinary	Purchase	126	45.17
Ordinary	Purchase	41	45.015
Ordinary	Purchase	90	44.985
Ordinary	Purchase	40	45.015
Ordinary	Purchase	132	45.015
Ordinary	Purchase	63	45.015
Ordinary	Purchase	100	45.015
Ordinary	Purchase	45	44.98
Ordinary	Purchase	63	45.11
Ordinary	Purchase	99	44.98
Ordinary	Purchase	48	44.98
Ordinary	Purchase	72	45.26
Ordinary	Purchase	26	45.175
Ordinary	Purchase	200	45.175
Ordinary	Purchase	266	45.175
Ordinary	Purchase	148	45.02
Ordinary	Purchase	108	45.02
Ordinary	Purchase	21	45.02
Ordinary	Purchase	80	44.985
Ordinary	Purchase	49	45.04
Ordinary	Purchase	125	45.1
Ordinary	Purchase	113	45.025
Ordinary	Purchase	91	45.105
Ordinary	Purchase	61	45.105
Ordinary	Purchase	21	45.105
Ordinary	Purchase	110	45.155
Ordinary	Purchase	59	45.155
Ordinary	Purchase	139	45.01
Ordinary	Purchase	52	45.17
Ordinary	Purchase	173	45.07
Ordinary	Purchase	2	45.08
Ordinary	Purchase	203	45.08
Ordinary	Purchase	188	45
Ordinary	Purchase	119	45.12
Ordinary	Purchase	92	45.005
Ordinary	Purchase	90	45.095
Ordinary	Purchase	96	45.105
Ordinary	Purchase	153	45.155
Ordinary	Purchase	21	45.155
Ordinary	Purchase	49	45.06
Ordinary	Purchase	75	45.06
Ordinary	Purchase	312	45.2
Ordinary	Purchase	16	45.015
Ordinary	Purchase	65	44.985
Ordinary	Purchase	60	45.18
Ordinary	Purchase	46	45.18
Ordinary	Purchase	80	45.18
Ordinary	Purchase	122	45.12
Ordinary	Purchase	69	45.12
Ordinary	Purchase	56	45.135
Ordinary	Purchase	54	45.02
Ordinary	Purchase	50	45.19
Ordinary	Purchase	84	45.085
Ordinary	Purchase	7	45.085
Ordinary	Purchase	49	45.03
Ordinary	Purchase	51	45.11
Ordinary	Purchase	29	45.015
Ordinary	Purchase	47	45.03
Ordinary	Purchase	43	45.125
Ordinary	Purchase	118	45.145
Ordinary	Purchase	30,800	45.30235526
Ordinary	Purchase	75,000	45.46138674
Ordinary	Purchase	40,000	45.39619503
Ordinary	Purchase	29,200	45.44842457
Ordinary	Purchase	863,391	45.015
Ordinary	Purchase	499	45.187783
Ordinary	Purchase	10,000	45.760379
Ordinary	Purchase	126,500	45.63518113
Ordinary	Purchase	11,377	45.06449
Ordinary	Purchase	50,000	45.966787
Ordinary	Purchase	11,377	45.06449
Ordinary	Purchase	160,000	45.236
Ordinary	Purchase	177,379	45.02
Ordinary	Purchase	157,621	45.09499
Ordinary	Purchase	145,800	45.072869
Ordinary	Purchase	29,200	45.0729
Class of relevant security	Purchase/sale	Number of securities	Price per unit USD
ADR	Purchase	14,757	170.039484
ADR	Purchase	6,519	169.66
ADR	Purchase	300	170.46
ADR	Purchase	45	169.56
ADR	Purchase	801	169.66
ADR	Purchase	195	169.66
ADR	Purchase	12,480	169.66
ADR	Purchase	3,600	169.66
Class of relevant security	Purchase/sale	Number of securities	Price per unit GBP
Ordinary	Sale	85	45.125
Ordinary	Sale	17,320	45.02
Ordinary	Sale	47	45.235
Ordinary	Sale	637	45.06
Ordinary	Sale	231	45.06
Ordinary	Sale	266	45.115
Ordinary	Sale	260	45.065
Ordinary	Sale	261	45.015
Ordinary	Sale	260	45.2
Ordinary	Sale	260	45.2
Ordinary	Sale	159	45.165
Ordinary	Sale	101	45.165
Ordinary	Sale	22	45.045
Ordinary	Sale	238	45.045
Ordinary	Sale	157	45.08
Ordinary	Sale	104	45.08
Ordinary	Sale	250	45.07
Ordinary	Sale	11	45.07
Ordinary	Sale	210	45.085
Ordinary	Sale	261	45.1
Ordinary	Sale	165	45.135
Ordinary	Sale	58	45.2
Ordinary	Sale	202	45.2
Ordinary	Sale	260	45.175
Ordinary	Sale	260	45.18
Ordinary	Sale	260	45.135
Ordinary	Sale	261	45.015
Ordinary	Sale	150	45.195
Ordinary	Sale	75	45.1
Ordinary	Sale	28	45.1
Ordinary	Sale	197	45.135
Ordinary	Sale	141	45.23
Ordinary	Sale	150	45.235
Ordinary	Sale	150	45.15
Ordinary	Sale	192	45.02
Ordinary	Sale	23	45.02
Ordinary	Sale	564	45.06
Ordinary	Sale	61	45.06
Ordinary	Sale	533	45.06
Ordinary	Sale	693	45.06
Ordinary	Sale	1,732	45.06
Ordinary	Sale	1,732	45.06
Ordinary	Sale	1,248	45.06
Ordinary	Sale	1,732	45.06
Ordinary	Sale	484	45.06
Ordinary	Sale	1,732	45.06
Ordinary	Sale	1,732	45.06
Ordinary	Sale	1,732	45.06
Ordinary	Sale	6,928	45.06
Ordinary	Sale	1,732	45.06
Ordinary	Sale	143	45.06
Ordinary	Sale	7,409	45.06
Ordinary	Sale	235	45.095
Ordinary	Sale	70	45.195
Ordinary	Sale	227	44.98
Ordinary	Sale	106	44.98
Ordinary	Sale	69	45.12
Ordinary	Sale	268	45.095
Ordinary	Sale	48	45.095
Ordinary	Sale	112	45.145
Ordinary	Sale	65	45.145
Ordinary	Sale	123	45.135
Ordinary	Sale	160	45.135
Ordinary	Sale	110	45.02
Ordinary	Sale	81	45.195
Ordinary	Sale	168	45.095
Ordinary	Sale	162	45.08
Ordinary	Sale	56	45.02
Ordinary	Sale	866,658	45.015
Ordinary	Sale	4,884	45.06
Ordinary	Sale	185,000	45.015
Ordinary	Sale	1,000	46.69099
Ordinary	Sale	11,377	45.06111
Ordinary	Sale	50,000	45.966787
Ordinary	Sale	11,377	45.06449
Ordinary	Sale	160,000	45.236
Ordinary	Sale	177,379	45.02
Ordinary	Sale	157,621	45.09499
Ordinary	Sale	145,800	45.072869
Ordinary	Sale	29,200	45.0729
Class of relevant security	Purchase/sale	Number of securities	Price per unit USD
ADR	Sale	6	170.48
ADR	Sale	51	169.462353
ADR	Sale	1,023	170.12
ADR	Sale	900	169.603333
ADR	Sale	900	169.953333
ADR	Sale	300	170.34
ADR	Sale	6,900	169.460435
ADR	Sale	36	169.13
ADR	Sale	600	169.415
ADR	Sale	21	169.53
ADR	Sale	9,588	170.029205
ADR	Sale	2,100	169.475714
ADR	Sale	1,152	169.66
ADR	Sale	4,560	169.66
	Total Purchases	1,978,383
	Total Sales	1,884,392

(b) Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit GBP
Ordinary	CFD	Increasing a short position	30,800	45.30235526
Ordinary	CFD	Increasing a short position	75,000	45.46138674
Ordinary	CFD	Increasing a short position	40,000	45.39619503
Ordinary	CFD	Increasing a short position	29,200	45.44842457
Ordinary	CFD	Increasing a short position	499	45.187783
Ordinary	CFD	Increasing a short position	10,000	45.760379
Ordinary	CFD	Increasing a short position	126,500	45.63518113
Ordinary	CFD	Reducing a short position	1,000	46.69099
Ordinary	Equity Linked Swap	Reducing a long position	863,391	45.015
Ordinary	Equity Linked Swap	Expiry	866,658	N/A

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit USD

ADR

Listed call-option

Purchasing

20,000

175

American

18/01/19

2.5

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit GBP

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) GBP

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Is a Supplemental Form 8 (Open Positions) attached?

Yes

Date of disclosure:	12/12/2018
Contact name:	Olivier Vero
Telephone number:	+44 20 7676 6969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

1. KEY INFORMATION

Full name of person making disclosure:	SOCIETE GENERALE SA
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Shire Plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit GBP	Type	Expiry date
Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates		e.g. American, European etc.	Expiry date
Ordinary	Listed call-option	Sale	150,000	32	American options	21/12/2018
Ordinary	Listed put-option	Sale	150,000	32	American options	21/12/2018
Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit USD	Type	Expiry date
ADR	Listed call-option	Sale	6,800	175	American options	18/01/2019
ADR	Listed call-option	Purchase	41,800	200	American options	18/01/2019
ADR	Listed call-option	Sale	15,000	185	American options	18/01/2019
ADR	Listed call-option	Purchase	33,900	190	American options	18/01/2019
ADR	Listed put-option	Purchase	30,000	140	American options	18/01/2019
ADR	Listed put-option	Sale	30,000	170	American options	18/01/2019
ADR	Listed put-option	Sale	20,000	155	American options	18/01/2019
ADR	Listed call-option	Sale	25,000	180	American options	18/01/2019

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RETEAEAAFAFPFFF

Date		Source	Headline
8th Jan 2019	5:30 pm	GNW	Director/PDMR Shareholding
8th Jan 2019	3:20 pm	RNS	Form 8.3 - Shire plc
8th Jan 2019	3:19 pm	RNS	Form 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 2019	3:13 pm	RNS	Form 8.3 - Shire plc
8th Jan 2019	3:07 pm	RNS	Form 8.5 (EPT/NON-RI)
8th Jan 2019	2:28 pm	RNS	Form 8.5 (EPT/RI) - Replacement of Shire
8th Jan 2019	2:23 pm	RNS	Form 8.5 (EPT/RI) - Replacement of Shire
8th Jan 2019	2:21 pm	RNS	Form 8.5 (EPT/RI) - Replacement of Shire
8th Jan 2019	1:57 pm	RNS	Form 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 2019	1:27 pm	RNS	Form 8.3 - Shire plc
8th Jan 2019	12:31 pm	RNS	Form 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 2019	12:29 pm	RNS	Form 8.3 - Takeda Pharmaceutical
8th Jan 2019	12:27 pm	RNS	Form 8.3 - Shire plc
8th Jan 2019	11:42 am	RNS	Form 8.5 (EPT/NON-RI)
8th Jan 2019	11:33 am	RNS	Form 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 2019	10:49 am	RNS	Form 8.5 (EPT/RI)
8th Jan 2019	10:41 am	RNS	Form 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 2019	10:26 am	RNS	Form 8.5 (EPT/RI)- Shire plc
8th Jan 2019	9:51 am	RNS	Form 8.3 - Shire Plc
8th Jan 2019	8:44 am	RNS	Form 8.5 (EPT/RI) - SHIRE PLC
8th Jan 2019	7:00 am	RNS	Form 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 2019	7:00 am	GNW	Scheme becomes effective
7th Jan 2019	5:00 pm	GNW	Holding(s) in Company
7th Jan 2019	3:42 pm	RNS	Form 8.5 (EPT/RI) - Amendment
7th Jan 2019	3:20 pm	RNS	Form 8.3 - Shire plc
7th Jan 2019	3:02 pm	RNS	Form 8.3 - Shire plc
7th Jan 2019	3:00 pm	RNS	Form 8.5 (EPT/NON-RI)
7th Jan 2019	3:00 pm	RNS	Form 8.3 - Shire plc
7th Jan 2019	2:59 pm	RNS	Form 8.3 - Takeda Pharmaceutical
7th Jan 2019	2:50 pm	PRN	Form 8.3 - Shire Plc
7th Jan 2019	2:49 pm	RNS	Form 8.3 - Shire plc
7th Jan 2019	2:47 pm	RNS	Form 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 2019	2:45 pm	BUS	Form 8.3 - Shire plc
7th Jan 2019	1:55 pm	RNS	Form 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 2019	1:54 pm	RNS	Form 8.3 - Shire plc
7th Jan 2019	1:39 pm	RNS	Form 8.3 - [Shire Plc]
7th Jan 2019	1:32 pm	RNS	Form 8.5 (EPT/RI) - Replacement of Shire
7th Jan 2019	1:29 pm	RNS	Form 8.5 (EPT/RI) - Replacement of Shire
7th Jan 2019	12:57 pm	RNS	Form 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 2019	12:56 pm	RNS	Form 8.3 - Shire plc
7th Jan 2019	12:42 pm	RNS	Form 8.5 (EPT/NON-RI)
7th Jan 2019	11:52 am	RNS	Form 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 2019	11:43 am	BUS	Form 8.3 - SHIRE PLC
7th Jan 2019	11:30 am	RNS	Form 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 2019	11:27 am	RNS	Form 8.3 - Shire plc
7th Jan 2019	11:01 am	RNS	Form 8.5 (EPT/RI)- Shire plc
7th Jan 2019	10:59 am	RNS	Form 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 2019	10:35 am	RNS	Form 8.5 - Shire plc
7th Jan 2019	10:16 am	RNS	Form 8.5 (EPT/RI) - SHIRE PLC
7th Jan 2019	10:13 am	RNS	Form 8.5 (EPT/RI) - Amendment

Latest Share Chat

Shire Regulatory News (SHP)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Shire Plc

Login to your account

Quickpicks are a member only feature

Login to your account